Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-17-000005

SVP of Operations acquired 110,849 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Plassche Douglas SVP of Operations 2017-02-23 Grant or award +110,849 $0.23 $24,996 285,879 D: show line 1 in the form
Loading xslF345X03/primary_doc.xml…